Published 14 hours ago • loading... • Updated 11 hours ago
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Xenon said the awards to eight employees and Alpha Cognition’s grant to one employee were approved as hiring inducements under Nasdaq rules.
On October 1, 2026, Xenon Pharmaceuticals Inc., Alpha Cognition Inc., and Taysha Gene Therapies, Inc. announced equity inducement grants to new employees under Nasdaq Listing Rule 5635.
Compensation committees at each firm approved the awards as material inducements to attract new hires, complying with Nasdaq rules permitting equity grants for employment incentives.
Xenon granted eight new non-officer employees 17,850 share options and 10,500 restricted share units, with vesting tied to continued service.
Taysha Gene Therapies issued 384,000 restricted share units and 92,400 share options to four employees; Alpha Cognition Inc. granted 6,000 options to one new hire.
These biopharmaceutical firms are advancing clinical-stage research for epilepsy, Alzheimer's disease, and Rett syndrome, strengthening teams to support drug development and commercialization.